Crescent Biopharma, Inc. (CBIO)
14.65
-0.10
(-0.71%)
USD |
NASDAQ |
Nov 12, 16:00
14.65
0.00 (0.00%)
After-Hours: 18:04
Crescent Biopharma Market Cap : 406.63M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 409.54M |
| November 10, 2026 | 386.36M |
| November 09, 2026 | 378.87M |
| November 06, 2026 | 375.82M |
| November 05, 2026 | 359.16M |
| November 04, 2026 | 383.59M |
| November 03, 2026 | 362.49M |
| November 02, 2026 | 358.33M |
| October 30, 2026 | 374.15M |
| October 29, 2026 | 390.53M |
| October 28, 2026 | 374.71M |
| October 27, 2026 | 368.32M |
| October 26, 2026 | 354.17M |
| October 23, 2026 | 355.83M |
| October 22, 2026 | 364.71M |
| October 21, 2026 | 365.55M |
| October 20, 2026 | 362.77M |
| October 19, 2026 | 343.06M |
| October 16, 2026 | 328.63M |
| October 15, 2026 | 346.39M |
| October 14, 2026 | 349.17M |
| October 13, 2026 | 358.33M |
| October 12, 2026 | 401.35M |
| October 09, 2026 | 413.84M |
| October 08, 2026 | 391.91M |
| Date | Value |
|---|---|
| October 07, 2026 | 374.43M |
| October 06, 2026 | 376.65M |
| October 05, 2026 | 386.92M |
| October 02, 2026 | 397.47M |
| October 01, 2026 | 395.80M |
| September 30, 2026 | 404.96M |
| September 29, 2026 | 409.68M |
| September 28, 2026 | 403.29M |
| September 25, 2026 | 388.31M |
| September 24, 2026 | 395.25M |
| September 23, 2026 | 393.86M |
| September 22, 2026 | 456.31M |
| September 21, 2026 | 451.04M |
| September 18, 2026 | 468.80M |
| September 17, 2026 | 465.47M |
| September 16, 2026 | 476.85M |
| September 15, 2026 | 521.81M |
| September 14, 2026 | 546.24M |
| September 11, 2026 | 538.74M |
| September 10, 2026 | 540.13M |
| September 09, 2026 | 554.84M |
| September 08, 2026 | 567.89M |
| September 04, 2026 | 579.55M |
| September 03, 2026 | 566.22M |
| September 02, 2026 | 514.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Encompass Health Corp. | 13.84B |
| Myriad Genetics, Inc. | 544.05M |
| BioRestorative Therapies, Inc. | 1.975M |
| U.S. Stem Cell, Inc. | 0.0634M |
| Marijuana, Inc. | 0.1653M |
Market Cap Related Metrics
| PS Ratio | 30.09 |
| Price to Book Value | 2.553 |
| Price | 14.65 |
| Earnings Yield | -52.20% |